Evidence map›Paper›PMID 24786770›Full record

ArticlePLoS genetics2014

Drosha promotes splicing of a pre-microRNA-like alternative exon.

Mallory A Havens, Ashley A Reich, Michelle L Hastings

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Let-7 Family as a Mediator of Exercise on Alzheimer's Disease.Cellular and molecular neurobiology · 2025
    Review
  7. miR-126: a bridge between cancer and exercise.Cancer cell international · 2025
    Review
  8. Regulation of the microprocessor by post-translational modifications.Frontiers in cell and developmental biology · 2025
    Review
  9. Review
  10. Article
  11. Noncanonical functions of microRNAs in the nucleus.Acta biochimica et biophysica Sinica · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Morphine modulates the expression of mu-opioid receptor exon 5-associated full-length C-terminal splice variants by upregulating miR-378a-3p.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mallory A HavensDepartment of Cell Biology and Anatomy, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America; School of Graduate and Postdoctoral Studies, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America.
Ashley A ReichDepartment of Biology, Lake Forest College, Lake Forest, Illinois, United States of America.
Michelle L HastingsDepartment of Cell Biology and Anatomy, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America; School of Graduate and Postdoctoral Studies, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America.
Rosalind Franklin University of Medicine and Science · USLake Forest College · US

Funding

Targeting SMN2 Alternative Splicing for the Treatment of Spinal Muscular AtrophyR01NS069759 · NINDS · ROSALIND FRANKLIN UNIV OF MEDICINE & SCI · PI HASTINGS, MICHELLE L · 2010 to 2014
$1.6M
LTQ Orbitrap Velos Mass Spectrometer with ETDS10OD010662 · OD · ROSALIND FRANKLIN UNIV OF MEDICINE & SCI · PI GLUCKSMAN, MARC J · 2012 to 2012
$600k
The Identification and Manipulation of RNA Splicing Factor Regulators in Spinal MF31NS076237 · NINDS · ROSALIND FRANKLIN UNIV OF MEDICINE & SCI · PI HAVENS, MALLORY ANN · 2011 to 2013
$86k
NIH HHS NCRR S10 OD010662NIH HHS S10 OD010662NINDS NIH HHS 1F31NS076237NINDS NIH HHS F31 NS076237NINDS NIH HHS NS069759NINDS NIH HHS R01 NS069759PHS HHS C76HF03610-01-00
6 · The paper itself

Abstract

The ribonuclease III enzyme Drosha has a central role in the biogenesis of microRNA (miRNA) by binding and cleaving hairpin structures in primary RNA transcripts into precursor miRNAs (pre-miRNAs). Many miRNA genes are located within protein-coding host genes and cleaved by Drosha in a manner that is coincident with splicing of introns by the spliceosome. The close proximity of splicing and pre-miRNA biogenesis suggests a potential for co-regulation of miRNA and host gene expression, though this relationship is not completely understood. Here, we describe a cleavage-independent role for Drosha in the splicing of an exon that has a predicted hairpin structure resembling a Drosha substrate. We find that Drosha can cleave the alternatively spliced exon 5 of the eIF4H gene into a pre-miRNA both in vitro and in cells. However, the primary role of Drosha in eIF4H gene expression is to promote the splicing of exon 5. Drosha binds to the exon and enhances splicing in a manner that depends on RNA structure but not on cleavage by Drosha. We conclude that Drosha can function like a splicing enhancer and promote exon inclusion. Our results reveal a new mechanism of alternative splicing regulation involving a cleavage-independent role for Drosha in splicing.

Indexed as

Alternative SplicingExonsAnimalsBase SequenceEukaryotic Initiation FactorsHEK293 CellsHeLa CellsHumansMicroRNAsMolecular Sequence DataRibonuclease IIIRNA PrecursorsSequence Homology, Nucleic AcidDROSHA protein, humanEIF4H protein, humanEukaryotic Initiation FactorsMicroRNAsRibonuclease IIIRNA Precursors

Identifiers

PMID24786770
PMCPMC4006729
OpenAlexW2081121203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.